Navigation Links
Sequenom Announces Publication Acceptance of Manuscript From Age-related Macular Degeneration Validation Study
Date:4/28/2011

SAN DIEGO, April 28, 2011 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced the acceptance for publication of the manuscript, "Clinical Validation of a Genetic Model to Estimate the Risk of Developing Choroidal Neovascular Age-related Macular Degeneration." The article will appear in the June issue of Human Genomics. The study, conducted by the company's wholly-owned subsidiary, Sequenom Center for Molecular Medicine (Sequenom CMM), was modeled using approximately 2000 case and control samples obtained from the University of Iowa, the University of Utah, Harvard University, Columbia University and the University of Melbourne.  

(Logo: http://photos.prnewswire.com/prnh/20040415/SQNMLOGO)

The successful completion and peer reviewed acceptance of this study for publication coincides with the introduction of RetnaGene™ AMD, a laboratory developed test (LDT) to assess the risk of developing Choroidal Neovascularization (CNV), the wet form of age-related macular degeneration (AMD), a common eye disorder of the elderly that can lead to blindness. The comprehensive set of genetic markers genotyped at the study centers were tested in a model to demonstrate the clinical validation of RetnaGene AMD LDT, providing the first commercial validation performed on a large collection of patients specifically targeting CNV.

"The LDT was designed to provide the most accurate assessment of risk based solely on genetic markers that are static through life and avoided inclusion of self-reported variables (e.g. smoking history) or non-static factors (BMI, education status) that might otherwise introduce inaccuracies in calculating a patient's risk of disease," said the lead author of the study, Dr. Gr
'/>"/>

SOURCE Sequenom, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Sequenom Announces Publication Acceptance of Manuscript From Trisomy 21 R&D Verification Study
2. Sequenom Announces Exercise in Full of Underwriters Option to Purchase Additional Shares
3. Sequenom Announces Formation of Ophthalmology Clinical Advisory Board
4. Sequenom to Present at Two Financial Conferences in September
5. Sequenom to Present at Two Financial Conferences in March
6. Sequenom Appoints Two New Board Members
7. SEQUENOM Announces Partnership With GeneWorks for Sales & Marketing of MassARRAY Systems and Applications in Australia
8. SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights
9. SEQUENOM Announces Launch of MassARRAY Compact 96 System
10. SEQUENOM to Hold First Quarter 2009 Financial Results Conference Call on April 30
11. Webcast Alert: Sequenom: Defining the Future of Noninvasive Prenatal Diagnostics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... October 20, 2014 Earle ... LLC, announced today that Ellen Teplitzky, an experienced ... for the pharmaceutical industry, has joined the firm ... its legal services practice. NDA Partners provides ... witness and testimony, to top law firms and ...
(Date:10/19/2014)... 2014 OCTOBER 20-22, 2014: ... ABIM will take place at the ... ABIM 2014 is now available at ... companies and organizations from all over the ... on the latest products and developments on ...
(Date:10/19/2014)... October 19, 2014 The Asian Automatic ... Asian with analysis and forecast of revenue. The Automatic ... to around $463.9 million by 2018, at a developing ... through the TOC of the Asian Automatic patient billing ... provided. This also provides a glimpse of the segmentation ...
(Date:10/19/2014)... Orthopedic braces and support systems report defines and segments the ... The Orthopedic braces and support systems market in Asia is ... a developing CAGR of 4.4% from 2013 to 2018. , ... support systems market, to get an idea of the in-depth ... of orthopedic braces and support systems market in the same ...
Breaking Biology Technology:NDA Partners Appoints Ellen Teplitzky, JD as Director of its Legal Services Practice 2The Asian Automatic patient billing market is estimated to grow to around $463.9 million by 2018 - New Report by MicroMarket Monitor 2The Asian Automatic patient billing market is estimated to grow to around $463.9 million by 2018 - New Report by MicroMarket Monitor 3The Asian Orthopedic braces and support systems market is estimated to grow to around $416.5 million by 2018 - New Report by MicroMarket Monitor 2The Asian Orthopedic braces and support systems market is estimated to grow to around $416.5 million by 2018 - New Report by MicroMarket Monitor 3The Asian Orthopedic braces and support systems market is estimated to grow to around $416.5 million by 2018 - New Report by MicroMarket Monitor 4
... ... to First Registrants , ... Westborough, MA (PRWEB) -- GenomeQuest, the world leader in sequence data management (SDM), ... a web cloud service to researchers around the world. , , , , ,The ...
... 10 Today, US Oncology, Inc . ... president and general counsel, will be departing from the Company, ... , Watts has had a long and rich history with ... providing legal services and consultation as an outside attorney before ...
... Nov. 10 DATATRAK International, Inc. (OTCQX: DATA), a ... for the clinical trials industry, today announced the award ... client, Symbio, LLC. A CRO specializing in dermatology, ... double data entry and EDC. In an effort ...
Cached Biology Technology:GenomeQuest Places ChIP-Seq Workflow Solution On SDM “Cloud” 2GenomeQuest Places ChIP-Seq Workflow Solution On SDM “Cloud” 3GenomeQuest Places ChIP-Seq Workflow Solution On SDM “Cloud” 4US Oncology Announces Retirement of General Counsel Phil Watts 2DATATRAK Signs New Client for Rescue Study 2DATATRAK Signs New Client for Rescue Study 3DATATRAK Signs New Client for Rescue Study 4
(Date:10/14/2014)... ATHENS, Ohio (Oct. 14, 2014)—It,s been millions of years ... but a team led by Ohio University scientists is ... to model airflow through dinosaur snouts. The research has ... not only breathe but to enhance the sense of ... pretty ,nosy, animals," said Ohio University doctoral student Jason ...
(Date:10/14/2014)... has discovered a new kind of stem cell that can ... liver blood vessels, according to a study published today in ... such a cell type contradicts current theory on how organs ... clues to origins of, and future treatment for, liver cancer., ... into a complex being made up of more than 200 ...
(Date:10/14/2014)... WORCESTER, MA – A team of scientists led ... School (UMMS) and the University of Miami Miller ... likely a key genetic pathway underlying bipolar (manic ... better drugs for treating bipolar affective disorder, as ... , The new findings, published online this week ...
Breaking Biology News(10 mins):Dinosaur breathing study shows that noses enhanced smelling and cooled brain 2Dinosaur breathing study shows that noses enhanced smelling and cooled brain 3Stem cell discovery challenges dogma on how fetus develops; holds insights for liver cancer and reg 2Stem cell discovery challenges dogma on how fetus develops; holds insights for liver cancer and reg 3Rare genetic disease protects against bipolar disorder 2Rare genetic disease protects against bipolar disorder 3
... June 29, 2011 BD Biosciences, a segment ... the availability of BD Recharge™, a chemically defined ... that offers productivity comparable to yeast-based peptones. ... advance for biopharmaceutical cell culture," said Robert Hallenbeck, ...
... A team of North Carolina State University researchers has discovered ... new brain cells in adults does its job. Their findings ... or disease. Most areas of the brain do not ... One exception is the olfactory bulb, the brain,s scent processor, ...
... Jerusalem, Israel The Israeli Chairmanship of EUREKA, the largest ... today in Jerusalem that since the start of Israel,s ... projects have been approved and supported by the program, ... Jerusalem for the fourth and final event held in ...
Cached Biology News:BD Biosciences Introduces Chemically Defined Cell Culture Media Supplement that Increases Biopharmaceutical Protein Production 2Genetic 'conductor' involved with new brain cell production in adults 2EUREKA invested over 300 million euros in industrial initiatives over the past year 2EUREKA invested over 300 million euros in industrial initiatives over the past year 3EUREKA invested over 300 million euros in industrial initiatives over the past year 4